Ginkgo Bioworks Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DNA | GENB | TECH | SANA | 688238.SS | GENO.ST | |
|---|---|---|---|---|---|---|
| Market cap | 784.51M | 1.82B | 11.42B | 766.36M | 4.36B | 1.47B |
| P/E (TTM) | — | — | 62.7 | — | — | 72.8 |
| Forward P/E | -4.0 | -6.2 | 31.5 | -4.6 | — | 46.5 |
| Price/book | 1.8 | 4.0 | 5.4 | 5.0 | 3.3 | 4.8 |
| Dividend yield | — | — | 0.44% | — | — | — |
| 1-year change | −7.16% | +9.49% | +25.01% | −36.79% | −14.27% | −4.08% |
| Today | +8.27% | +2.24% | +0.10% | +4.92% | +5.49% | +3.31% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DNA news ›Ginni Filaments GINNIFILA Physical Share Transfer Report Oct 2026
Kalkine India Ginni Filaments (NSE:GINNIFILA): What Does Its October 2026 Physical Share Transfer Report Show? Source: Krish Capital Pty Ltd Ginni Filaments Limited (NSE:GINNIFILA) submitted its monthly compliance report on 3 Novembe
Assembly Biosciences officer proposes $50.9K stock sale
Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue Growth of 96% Y/Y; Raises FY 2026 Revenue Guidance to 91% Y/Y Growth and U.S. Comm Revenue Guidance to 143% Y/Y, Crushing Consensus Expectations Aehr Test Systems…
Hainan Haiyao plans to unload stake in SinoMab BioScience
Hainan Haiyao Co Ltd: Says co plans to unload up to 5% stake in SinoMab BioScience Ltd ... Hainan Haiyao Co., Ltd. Hainan Haiyao plans to unload stake in SinoMab BioScience Published on 04/03/2026 at 09:33 am EDT
Reviewing Bullfrog AI (NASDAQ:BFRG) & Ginkgo Bioworks (NYSE:DNA)
Posted by Sarita Garza on Oct 24th, 2026 Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Bullfrog AI (NASDAQ:BFRG – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two…
MeiraGTx officer proposes sale of 56,000 shares
GameSquare Announces The "Grand Theft Auto" Effect Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update Cipher Digital Announces Date of Third Quarter 2026 Business Update Conference Call The securities…
Cytokinetics officer proposes $1.03M share sale
Netflix Reports Q3 2026 Earnings: Revenue Rises 12% to $12.87 Billion, Operating Margin 34.6% INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Peraso Receives Production Order Exceeding $2.0…
DNA Surges As Ginkgo Bioworks Lands Key AI Drug Deals
Ginkgo Bioworks Holdings Inc. stocks have been trading up by 14.81 percent amid heightened optimism over its synthetic biology platform What Traders Need To Know New data-generation agreement with Eli Lilly’s TuneLab embeds Ginkgo Bioworks…
Ginkgo Bioworks (NYSE:DNA) versus MindWalk (NASDAQ:HYFT) Head-To-Head Comparison
Posted by Mitch Edgeman on Oct 11th, 2026 MindWalk (NASDAQ:HYFT – Get Free Report) and Ginkgo Bioworks (NYSE:DNA – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies…
From Boxabl to Ginkgo Bioworks: A Startup Advisory Practice Built on a Decade of Early Investments and Exits
IndyStar From Boxabl to Ginkgo Bioworks: A Startup Advisory Practice Built on a Decade of Early Investments and Exits Performance Psychology Group relaunches as an advisory spanning healthca
Ginkgo Bioworks: The Valuation Has Outrun The Business
Ginkgo Bioworks receives a reiterated 'Sell' rating, as recent AI/biotech enthusiasm has driven the stock far ahead of fundamentals. Learn more about DNA stock here. - Ginkgo Bioworks receives a reiterated 'Sell' rating, as recent…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net11
- themarketsdaily.com3
- seekingalpha.com2
- indystar.com1
- marketscreener.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.